Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diltiazem pharmaceutical spheroid formulation

Diltiazem pharmaceutical spheroid formulation

US Patent 5508044 · Granted Apr 16, 1996

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorop2025
Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phe2022
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorop2021
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorop2021
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)- N′-(4-fluoro2021
Oxycodone formulations2020
Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phe2020
Delayed release pharmaceutical formulations2019
Buprenorphine-wafer for drug substitution therapy2018
Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophe2017
Opioid composition for treating skin lesions2017
Buprenorphine-wafer for drug substitution therapy2017